Correlation Between Viemed Healthcare and Transcode Therapeutics

Can any of the company-specific risk be diversified away by investing in both Viemed Healthcare and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viemed Healthcare and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viemed Healthcare and Transcode Therapeutics, you can compare the effects of market volatilities on Viemed Healthcare and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viemed Healthcare with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viemed Healthcare and Transcode Therapeutics.

Diversification Opportunities for Viemed Healthcare and Transcode Therapeutics

0.35

Correlation Coefficient

Viemed Healthcare  Transcode Therapeutics

Weak diversification

The 3 months correlation between Viemed and Transcode is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Viemed Healthcare and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Viemed Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viemed Healthcare are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Viemed Healthcare i.e., Viemed Healthcare and Transcode Therapeutics go up and down completely randomly.

Pair Corralation between Viemed Healthcare and Transcode Therapeutics

Considering the 90-day investment horizon Viemed Healthcare is expected to generate 15.12 times less return on investment than Transcode Therapeutics. But when comparing it to its historical volatility, Viemed Healthcare is 3.09 times less risky than Transcode Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  697.00  in Transcode Therapeutics on April 14, 2025 and sell it today you would earn a total of  172.00  from holding Transcode Therapeutics or generate 24.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Viemed Healthcare  vs.  Transcode Therapeutics

Viemed Healthcare

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Viemed Healthcare are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound primary indicators, Viemed Healthcare is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Transcode Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Transcode Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Transcode Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Viemed Healthcare and Transcode Therapeutics

The main advantage of trading using opposite Viemed Healthcare and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viemed Healthcare position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.

The idea behind Viemed Healthcare and Transcode Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.